| Systematic (IUPAC) name | |
|---|---|
| 1-(5-nitro-1,3-thiazol-2-yl)imidazolidin-2-one | |
| Clinical data | |
| MedlinePlus | a682128 |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 61-57-4 |
| ATC code | P02BX02 |
| PubChem | CID 6093 |
| UNII | N116U8Y5QQ |
| KEGG | D05170 |
| Chemical data | |
| Formula | C6H6N4O3S |
| Mol. mass | 214.20 g/mol |
| |
|
Niridazole is a schistosomicide.[1] It is used to treat schistosomiasis, the helmintic disease caused by certain flatworms (trematodes) from the genus Schistosoma (formerly Bilharzia). It is also known by its trade name Ambilgar. It is usually is given as tablets. Niridazole has central nervous system toxicity and can cause dangerous side effects, such as hallucinations. Also, it may cause allergic reactions in sensitive people. However, it is one of the most effective schistosomicide drugs.
It has recently also been investigated for use in the treatment of periodontitis.[2][3]
Niridazole is rapidly concentrated in the parasite and inhibits oogenesis and spermatogenesis. The compound also inhibits the phosphofructokinase enzyme, leading to glycogen depletion and hepatic shift.
|
||||||||||||||||||||||||||||||||||||||||||
| This antiinfective drug article is a stub. You can help Wikipedia by expanding it. |
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)